Updated Jul 16, 2026
Huang James has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $4.37M.
James Huang is associated with Connect Biopharma Holdings Ltd, a company focused on developing innovative therapies for patients with autoimmune and inflammatory diseases. Specific details about his role and contributions to the company are limited in publicly available resources.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | CNTB | Connect Biopharma Holdings Ltd | P — Open-market purchase | 150.0K | $2.48 | $372K |
| 2026-04-01 | CNTB | Connect Biopharma Holdings Ltd | P — Open-market purchase | 1.16M | $3.45 | $4.00M |
James Huang is associated with Connect Biopharma Holdings Ltd, a company focused on developing innovative therapies for patients with autoimmune and inflammatory diseases. Specific details about his role and contributions to the company are limited in publicly available resources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($4.37M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Huang James profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.